In Brief: Vitamin E study
This article was originally published in The Tan Sheet
Executive Summary
Vitamin E study: Anticlotting action of vitamin E quinone may explain the vitamin's observed beneficial effects on heart disease and stroke, University of Pittsburgh researchers note in the August Proceedings of the National Academy of Sciences. "We suggest that the attendant anticoagulant properties of vitamin E quinone 2 be taken into consideration when assessing the effectiveness of vitamin E in attenuating the likelihood of the onset of ischemic heart attack and ischemic stroke," Paul Dowd and Zhizhen Zheng conclude. They add that vitamin E quinone 2's "use as an anticoagulant might be explored as an alternative or supplement to warfarin and Coumadin"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning